CRISPR/Cas9 potential applications in cancer immunotherapy by gene-editing and immune checkpoint signaling pathway inhibition
Crossref DOI link: https://doi.org/10.32948/ajsep.2024.12.25
Published Online: 2025-12-31
Published Print: 2024-12-31
Update policy: https://doi.org/10.32948/asme.crossmark.policy
Ishfaq, Mehab
Publication History
Received: 2024-8-27
Accepted: 2024-12-23
Published Online: 2024-12-31
